◀ Back to CD79A

CD79A — TGFB3

Text-mined interactions from Literome

Goodrich et al., Cytokine 1998 : Depletion of the IEC-6 supernatant using cytokine specific antibodies revealed that both interleukin 6 (IL-6) and transforming growth factor beta ( TGF-beta ) were responsible for the enhanced IgA secretion while TGF-beta suppressed IgM secretion
Lai et al., J Am Soc Nephrol 2003 (Glomerulonephritis, IGA) : Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system
Ogawa et al., Early Hum Dev 2004 : Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants
Coffman et al., Semin Immunol 1989 : Recent evidence suggests that transforming growth factor-beta induces switching to IgA , despite the inhibitory activity on other isotypes
Hummelshoj et al., Scand J Immunol 2006 : All analogues reduced anti-CD40 Ab + transforming growth factor ( TGF ) -beta induced IgA production compared with cultures stimulated with anti-CD40 Ab and TGF-beta alone
Massacand et al., PloS one 2008 : The ability of PP-DC to promote anti-CD40 dependent IgA was partially dependent on retinoic acid ( RA ) and transforming growth factor ( TGF ) -beta , whilst BAFF and APRIL signaling were not required
Smits et al., Mucosal Immunol 2009 (Disease Models, Animal...) : CTB caused a transforming growth factor-beta dependent rise in antigen-specific IgA in the airway luminal secretions, which was necessary for its preventive and curative effect, as all effects of CTB were abrogated in mice lacking the luminal IgA transporting polymeric Ig receptor
Armitage et al., J Immunol 1993 : Although transforming growth factor-beta only partially inhibited secretion of IgM, IgG1, and IgA , it was strongly suppressive for IgG4 and IgE production